MetrioPharm AG
Industry / private company
Location:
Zurich,
Switzerland (CH)
Novel, orally available immune modulator MP1032 with pan-variant anti-SARS-CoV-2 and anti-inflammatory activity (2022)
Schumann S, Setz C, Schulz P, Kaiser A, Schubert U, Brysch W
Conference contribution
Immune‐modulating drug MP1032 with SARS‐CoV‐2 antiviral activity in vitro: A potential multi‐target approach for prevention and early intervention treatment of COVID‐19 (2020)
Schumann S, Kaiser A, Nicoletti F, Mangano K, Fagone P, van Wijk E, Yan Y, et al.
Journal article